Stockreport

Tvardi Therapeutics to Participate in Upcoming Investor Conferences

Tvardi Therapeutics, Inc.  (TVRD) 
PDF HOUSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development o [Read more]